The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The Fc and not CD4 Receptor Mediates Antibody Enhancement of HIV Infection in Human Cells
Abstract
Antibodies that enhance human immunodeficiency virus (HIV) infectivity have been found in the blood of infected individuals and in infected or immunized animals. These findings raise serious concern for the development of a safe vaccine against acquired immunodeficiency syndrome. To address the in vivo relevance and mechanism of this phenomenon, antibody-dependent enhancement of HIV infectivity in peripheral blood macrophages, lymphocytes, and human fibroblastoid cells was studied. Neither Leu3a, a monoclonal antibody directed against the CD4 receptor, nor soluble recombinant CD4 even at high concentrations prevented this enhancement. The addition of monoclonal antibody to the Fc receptor III (anti-FcRIII), but not of antibodies that react with FcRI or FcRII, inhibited HIV type 1 and HIV type 2 enhancement in peripheral blood macrophages. Although enhancement of HIV infection in CD4+ lymphocytes could not be blocked by anti-FcRIII, it was inhibited by the addition of human immunoglobulin G aggregates. The results indicate that the FcRIII receptor on human macrophages and possibly another Fc receptor on human CD4 + lymphocytes mediate antibody-dependent enhancement of HIV infectivity and that this phenomenon proceeds through a mechanism independent of the CD4 protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
"Panning" for lymphocytes: a method for cell selection.
Wysocki, L. J., & Sato, V. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2844 · Cited by 1,294
Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 Molecule
McDougal, J. S., Kennedy, M. S., Sligh, J. M., Cort, S. P., Mawle, A., & Nicholson, J. K. A. (1986) · Science · doi:10.1126/science.3001934 · Cited by 989
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes
Klatzmann, D., Barré-Sinoussi, F., Nugeyre, M. T., Danguet, C., Vilmer, E., Griscelli, C., Brun-Veziret, F., Rouzioux, C., Gluckman, J. C., Chermann, J.-C., et al. (1984) · Science · doi:10.1126/science.6328660 · Cited by 969
soluble form of CD4 (T4) protein inhibits AIDS virus infection
Deen, K. C., McDougal, J. S., Inacker, R., Folena-Wasserman, G., Arthos, J., Rosenberg, J., Maddon, P. J., Axel, R., & Sweet, R. W. (1988) · Nature · doi:10.1038/331082a0 · Cited by 527
Blocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 Antigen
Smith, D. H., Byrn, R. A., Marsters, S. A., Gregory, T., Groopman, J. E., & Capon, D. J. (1987) · Science · doi:10.1126/science.3500514 · Cited by 485
Structure and Function of Human and Murine Receptors for IgG
Unkeless, J. C., Scigliano, E., & Freedman, V. H. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.001343 · Cited by 470
Antibody-Enhanced Infection by HIV-1 Via Fc Receptor-Mediated Entry
Takeda, A., Tuazon, C. U., & Ennis, F. A. (1988) · Science · doi:10.1126/science.2972065 · Cited by 460
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients
Weiss, R. A., Clapham, P. R., Cheingsong-Popov, R., Dalgleish, A. G., Carne, C. A., Weller, I. V. D., & Tedder, R. S. (1985) · Nature · doi:10.1038/316069a0 · Cited by 452
HIV infection is blocked in vitro by recombinant soluble CD4
Fisher, R. A., Bertonis, J. M., Meier, W., Johnson, V. A., Costopoulos, D. S., Liu, T., Tizard, R., Walker, B. D., Hirsch, M. S., Schooley, R. T., et al. (1988) · Nature · doi:10.1038/331076a0 · Cited by 446
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
The Immunopathogenesis of Human Immunodeficiency Virus Infection
Epstein, F. H., Pantaleo, G., Graziosi, C., & Fauci, A. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280508 · Cited by 1,189
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Self-citationBanda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R. P., & Finkel, T. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1099 · Cited by 668
Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., & Eichberg, J. W. (1990) · Nature · doi:10.1038/345622a0 · Cited by 590
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Antibody-Dependent Enhancement of Virus Infection and Disease
Tirado, S. M. C., & Yoon, K.-J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 313
Role of Mononuclear Phagocytes in the Pathogenesis of Human Immunodeficiency Virus Infection
Meltzer, M. S., Skillman, D. R., Gomatos, P. J., Kalter, D. C., & Gendelman, H. E. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001125 · Cited by 271
The antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.956-965.1992 · Cited by 179
Metadata
- Authors
- Homsy, J., Meyer, M., Tateno, M., Clarkson, S., & Levy, J. A.
- Venue
- Science
- Published
- 1989-06-16
- Volume
- 244
- Issue
- 4910
- Pages
- 1357-1360
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2054119768
- Cited by
- 330
- References
- 22
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.